Who invested in Pathogenetix?
Pathogenetix's investors include HealthCare Ventures, Excel Venture Management, Ascension Ventures and CB Health Ventures.
United States · Series C startup
6 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$25Mraised across 6 rounds since 2010, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finsmes.comSEC filing: $3.6M sold, first sale Oct 2013
Reported by masshightech.comSEC filing: $11M sold, first sale Jul 2011
Reported by pathogenetix.comSEC filing: $4.0M sold, first sale Jul 2011
No investor was named in the report.
From a historical funding recordSEC filing: $1.5M sold, first sale Oct 2010
No investor was named in the report.
Reported by masshightech.comSEC filing: $1.3M sold, first sale Oct 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Pathogenetix's investors include HealthCare Ventures, Excel Venture Management, Ascension Ventures and CB Health Ventures.
Pathogenetix has raised $25M across 6 rounds since 2010.
Pathogenetix's most recent round was a Series C of $10M in Oct 2013.
Its most recent round, $10M in Oct 2013, is also its largest on record.
Pathogenetix's first round on record, in Aug 2011, was backed by HealthCare Ventures, Excel Venture Management and CB Health Ventures.
Pathogenetix's latest named round is a Series C, in Oct 2013.
Pathogenetix is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.